Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study for the Adjuvant Treatment of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4
A Study for the Neoadjuvant Treatment of Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4
A Dose-finding Trial of Hyperthermic Intraperitoneal Docetaxel
- Status
- UNKNOWN
- Phase
- PHASE1
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations
- Status
- SUSPENDED
- Phase
- PHASE3
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3